Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 18, 2026The BreastOpen Access

Pembrolizumab plus chemotherapy followed by pembrolizumab in participants in Asia with early triple-negative breast cancer: An updated subgroup analysis of the KEYNOTE-522 randomized clinical trial

View Full Paper
Ask AI
Bookmark
Share

Authors

YPYeon Hee ParkRHRina HuiSISeock-Ah Im

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Park et al. (2026) studied this question.

synapsesocial.com/papers/6aac89e028dacefbf66e0175https://doi.org/10.1016/j.breast.2026.104904
View Full Paper
Ask AI
Bookmark
Share